1. Minimally Invasive Surgery
(1) Robot Assisted Radical Prostatectomy + BPLND and NVBP procedure
(2) Transoral Robotic Surgery without Tracheostomy for Hypopharyngeal Cancer
(3) Endoscope Assisted Vitrectomy
2. ENT Innovative Treatment
(1) Olfactory Appraisal and Treatment Center First Integrated Traditional Chinese and Western Medicine Therapy
(2) Laryngeal Electromyography Guided Hyaluronic Acid Vocal Fold Injection
3. Cardiovascular Innovative Technology
(1) Innovative Technique for Transcatheter Treatment of Congenital Heart Diseases
(2) Comprehensive Care of Heart Failure
4. Neonatal Innovative Caring Products
(1) Nasal CPAP Fixation Strap
(2) Position Auxiliary-nest
(3) Kangaroo Blanket
(4) Newborn Eye Protector
5. Innovative Products
(1) The Development of Kinematic Institutions of Intelligent Patient Bed and Assistive Devices with Chronically Ill Man
(2) A Platform and Method for Detection / Quantity Hepatitis B Viruses
(3) The Detection Kit of Dust Mite
(4) Device and Method for Real-time Cardiopulmonary Rehabilitation Treatment with a Remote Automatic Monitoring Function
(5) Device for Fecal Occult Blood Test
1. Taigexyn® - Nemonoxacin
Novel Antibiotic for Drug-Resistant Bacterial Infections
(1) The first Class 1.1 new drug developed by a Taiwanese company to receive market approval in mainland China
(2) Superior activity against drug resistant pathogens–especially MRSA, Quinolone-resistant MRSA and Streptococcus pneumoniae
(3) Approved and launched in Taiwan and China
(4) Available in both oral and intravenous formulations
(5) Granted Qualified Infectious Disease Product (QIDP) and Fast Track designations by US FDA
(6) Out-licensed and partnered successfully in Russia, Commonwealth Independent States, Turkey, Mexico, Brazil and Latin America
2. Furaprevir (TG-2349)
Potent NS3/4A protease inhibitor
Anchor in HCV Cocktail Regiment
(1) Active against all six genotypes of Hepatitis C virus (HCV)
(2) Oral once-a –day dosing with only minimal side effects
(3) Joint development with HEC Pharmaceuticals' DAG-181 (NS5a inhibitor) for an all-oral interferon-free treatment of HCV in Greater China
3. Burixafor (TG-0054)
Next generation stem cell mobilizer
(1) Selective CXCR4 antagonist that mobilize stem cells and cancer cells from the bone marrow into peripheral circulation.
(2) Simplify collection and banking of hematopoietic stem cells for HSCT
Taipei Beitou Health Management Hospital designs a humanistic, healthy and leisurely vacation to fulfill the idea of Holistic Medicine. People can have tailor-madepersonalized health checkup with aesthetic medicine, healthy diets, and physical fitness, combining psychological, ecological and even spiritual programs as well as 5-star-quality accommodations while appreciating Beitou local culture. Medical tourism service addresses every need of you and your family.
1. International Healthcare Professionals Training Program
2. International Patient Referral and Examination Services
Rapid, Reliable, New Anti Cancer Drug Screening Model: MTAM/Screen
Personalized Anti-Cancer Drug Selection Service: MTAM/Select